| 1 |
Chen W, Bai Z, Bai W, Wang W, Guo J, Guo M, Sai Y, Shi J, Wu J. LncTUG1 contributes to the progression of hepatocellular carcinoma via the miR-144-3p/RRAGD axis and mTOR/S6K pathway.. [DOI: 10.21203/rs.3.rs-2111715/v1] [Reference Citation Analysis]
|
| 2 |
Rao Z, Li H, Yao W, Wang Q, Ma B, Xue D, Meng X. A novel HCC prognosis predictor PDSS1 affects the cell cycle through the STAT3 signaling pathway in HCC. Front Oncol 2022;12:927468. [DOI: 10.3389/fonc.2022.927468] [Reference Citation Analysis]
|
| 3 |
Testino G. Surveillance for hepatocellular carcinoma after hepatitis C virus eradication. Minerva Med 2022;113. [DOI: 10.23736/s0026-4806.20.06496-4] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 4 |
Cabiati M, Gaggini M, De Simone P, Del Ry S. Data mining of key genes expression in hepatocellular carcinoma: novel potential biomarkers of diagnosis prognosis or progression. Clin Exp Metastasis 2022. [PMID: 35429302 DOI: 10.1007/s10585-022-10164-9] [Reference Citation Analysis]
|
| 5 |
Ali MAM, Harmsen WS, Morsy KH, Galal GMK, Therneau TM, Roberts LR. Prognostic utility of systemic inflammatory markers and chronic hepatitis C virus infection status in hepatocellular carcinoma patients treated with local ablation. BMC Cancer 2022;22:221. [PMID: 35227234 DOI: 10.1186/s12885-021-09121-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 6 |
Abdel-Razik A, Shabana W, El Nakib AM, Abdelsalam M, Abdelwahab A, Hasan AS, Elzehery R, Elhelaly R, Fathy AA, Mostafa SA, El-Wakeel N, Moemen D, Eldars W, Yassen AH. De Novo Hepatocellular Carcinoma in Hepatitis C-Related Cirrhosis: Are Advanced Glycation End Products a Key Driver? Front Cell Infect Microbiol 2021;11:662431. [PMID: 34660332 DOI: 10.3389/fcimb.2021.662431] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 7 |
Matli VVK, Dhahri A, Boda Eswara V, Green LD. Chest Wall Swelling in a Baby Boomer: An Unusual Presentation of Primary Hepatocellular Carcinoma. Cureus 2021;13:e18163. [PMID: 34567914 DOI: 10.7759/cureus.18163] [Reference Citation Analysis]
|
| 8 |
Liu G, Guo W, Rao M, Qin J, Hu F, Li K. circRNA hsa_circ_104566 Sponged miR-338-3p to Promote Hepatocellular Carcinoma Progression. Cell Transplant 2020;29:963689720963948. [PMID: 33028110 DOI: 10.1177/0963689720963948] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 9 |
Li J, Yu Z, Zhu Q, Tao C, Xu Q. hsa_circ_102559 Acts as the Sponge of miR-130a-5p to Promote Hepatocellular Carcinoma Progression Through Regulation of ANXA2. Cell Transplant 2020;29:963689720968748. [PMID: 33121269 DOI: 10.1177/0963689720968748] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 10 |
Mostafa A, Ibrahim NE, Sabry D, Fathy W, Elkazaz AY. Insulin-like Growth Factor Initiates Hepatocellular Carcinoma in Chronic Hepatitis C Virus Patients through Induction of Long Non-coding Ribonucleic Acids AF085935. Open Access Maced J Med Sci 2021;9:222-228. [DOI: 10.3889/oamjms.2021.5909] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 11 |
Caviglia GP, Abate ML, Rolle E, Carucci P, Armandi A, Rosso C, Olivero A, Ribaldone DG, Tandoi F, Saracco GM, Ciancio A, Bugianesi E, Gaia S. The Clinical Role of Serum Epidermal Growth Factor Receptor 3 in Hepatitis C Virus-Infected Patients with Early Hepatocellular Carcinoma. Biology (Basel) 2021;10:215. [PMID: 33799723 DOI: 10.3390/biology10030215] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 12 |
Armandi A, Caviglia GP, Saracco GM, De Marco L, Fagoonee S, Pellicano R. Seronegative occult hepatitis C virus infection: what is its clinical relevance? Minerva Biotecnol 2020;32. [DOI: 10.23736/s1120-4826.20.02637-3] [Reference Citation Analysis]
|
| 13 |
Rosso C, Caviglia GP, Armandi A, Abate ML, Olivero A, Ribaldone DG, Pellicano R, Saracco GM, Bugianesi E. Performance of cytokeratin-18 apoptotic fragment for the identification of hepatic fibrosis and inflammation in patients with chronic viral hepatitis: a meta-analysis. Minerva Biotecnol 2020;32. [DOI: 10.23736/s1120-4826.20.02681-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 14 |
Caviglia GP, Ciruolo M, Abate ML, Carucci P, Rolle E, Rosso C, Olivero A, Troshina G, Risso A, Nicolosi A, Ribaldone DG, Armandi A, Tandoi F, Saracco GM, Bugianesi E, Ciancio A, Gaia S. Alpha-Fetoprotein, Protein Induced by Vitamin K Absence or Antagonist II and Glypican-3 for the Detection and Prediction of Hepatocellular Carcinoma in Patients with Cirrhosis of Viral Etiology. Cancers (Basel) 2020;12:E3218. [PMID: 33142893 DOI: 10.3390/cancers12113218] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 15 |
Fang Q, Liu H, Zhou A, Zhou H, Zhang Z. Circ_0046599 Promotes the Development of Hepatocellular Carcinoma by Regulating the miR-1258/RPN2 Network. Cancer Manag Res 2020;12:6849-60. [PMID: 32801909 DOI: 10.2147/CMAR.S253510] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 16 |
Testino G, Leone S, Fagoonee S. Hepatitis C virus, alcohol use disorders and hepatocellular carcinoma. Panminerva Med 2020;62. [DOI: 10.23736/s0031-0808.18.03515-2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 17 |
Li J, Wang X, Yang J, Zhao S, Liu T, Wang L. Identification of Hub Genes in Hepatocellular Carcinoma Related to Progression and Prognosis by Weighted Gene Co-Expression Network Analysis. Med Sci Monit 2020;26:e920854. [PMID: 32200387 DOI: 10.12659/MSM.920854] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 18 |
Karwowska, Szemraj, Karwowski. Microbiota Alterations in Gastrointestinal Cancers. Applied Sciences 2020;10:585. [DOI: 10.3390/app10020585] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 19 |
Liu XN, Cui DN, Li YF, Liu YH, Liu G, Liu L. Multiple “Omics” data-based biomarker screening for hepatocellular carcinoma diagnosis. World J Gastroenterol 2019; 25(30): 4199-4212 [PMID: 31435173 DOI: 10.3748/wjg.v25.i30.4199] [Cited by in CrossRef: 33] [Cited by in F6Publishing: 37] [Article Influence: 8.3] [Reference Citation Analysis]
|
| 20 |
Liu X, Cui D, Li Y, Liu Y, Liu G, Liu L. Multiple “Omics” data-based biomarker screening for hepatocellular carcinoma diagnosis. WJG 2019;25:4199-212. [DOI: 10.3748/wjg.v25.i29.4199] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 21 |
Tolentino B, Singh RR, Misra S, Dieterich DT, Sarpel D. An update on the management of hepatitis C virus and human immunodeficiency virus co-infection. Future Virology 2019;14:185-195. [DOI: 10.2217/fvl-2018-0116] [Reference Citation Analysis]
|
| 22 |
Hong N, Zhang N, Wu H, Lu S, Yu Y, Hou L, Lu Y, Liu H, Jiang G. Preliminary exploration of survival analysis using the OHDSI common data model: a case study of intrahepatic cholangiocarcinoma. BMC Med Inform Decis Mak 2018;18:116. [PMID: 30526572 DOI: 10.1186/s12911-018-0686-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 23 |
Berrutti M, Leone N. Helicobacter species and liver: new insights in an intriguing field. Minerva Biotecnol 2018;30. [DOI: 10.23736/s1120-4826.18.02489-8] [Reference Citation Analysis]
|
